Latest / Making it in Manufacturing
The CEO’s Weekly Challenge: Capacity or Indication | CPHI Milan 2026 CEO Panel
This week on Making It In Manufacturing, we’re bringing you our CEO panel from CPHI Milan 2026. ARTO Co-Founder and CEO Elliot Payne sat down with three CDMO CEOs: Dr Hanns-Christian Mahler of ten23 health, Dr Adriana Kiędzierska-Mencfeld of Rezon Bio and Philippe Clavel of Curapath, to ask how they weigh capacity risk against indication risk.
In this panel:
- Why ordering a sterile filling machine today can mean five to seven years before the first GMP fill
- How Rezon Bio builds capacity in stages, and why the team is the biggest asset and the biggest risk
- How Curapath helped an ALS…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.